Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Primary Vitreoretinal Lymphoma with or without Intracranial Involvement: A Single Center Experience

Ethan A Burns, Noah Giese, Shubham Adroja, Sunil Mathur, Chih-Hang Anthony Tang, Chih-Chi Andrew Hu, Shilpan S. Shah, Bin S Teh, Amy Schefler, Sai Ravi Pingali

Blood (2024) 144 (Supplement 1): 1716.

https://doi.org/10.1182/blood-2024-210381

Published: 2024

Journal Articles

RARγ activation sensitizes human myeloma cells to carfilzomib treatment through the OAS-RNase L innate immune pathway

Qiang Wang, Zhijuan Lin, Zhuo Wang, Lingqun Ye, Miao Xian, Liuling Xiao, Pan Su, Enguang Bi, Yung-hsing Huang, Jianfei Qian, Lintao Liu, Xingzhe Ma, Maojie Yang, Wei Xiong, Youli Zu, Sai Ravi Pingali, Bing Xu, Qing Yi

Blood (2022) 139 (1): 59–72.

https://doi.org/10.1182/blood.2020009856

Published: 2022

Includes: Supplemental data

Journal Articles

MIF as a biomarker and therapeutic target for overcoming resistance to proteasome inhibitors in human myeloma

Qiang Wang, Dongyu Zhao, Miao Xian, Zhuo Wang, Enguang Bi, Pan Su, Jianfei Qian, Xingzhe Ma, Maojie Yang, Lintao Liu, Youli Zu, Sai Ravi Pingali, Kaifu Chen, Zhen Cai, Qing Yi

Blood (2020) 136 (22): 2557–2573.

https://doi.org/10.1182/blood.2020005795

Published: 2020

Includes: Supplemental data

Journal Articles

An Integer Weighted Genomic Mutation Scoring (IWGMS) Using the Trusight Myeloid Sequencing Panel (Illumina) Shows Higher Mortality in Patients with Intermediate Risk Acute Myeloid Leukemia- a Retrospective Study

Xinyu Nan, MD, Michael Greenwood, MD, Cesar Gentille Sanchez, MD, Yan Xing, MD PhD, Arthur Zieske, MD, Ibrahim Ibrahim, MD, Kelty Baker, MD, Lawrence Rice, MD, Brian Merritt, Sai Ravi Pingali, MD, Randall J Olsen, MD, Swaminathan P. Iyer, MD

Blood (2016) 128 (22): 2889.

https://doi.org/10.1182/blood.V128.22.2889.2889

Published: 2016

Journal Articles

Impact of Routine Surveillance Imaging on Outcomes in Patients with Classical Hodgkin Lymphoma (cHL) Undergoing Autologous Hematopoietic Cell Transplantation (auto-HCT)

Jonathan Kapke, DO, Narendranath Epperla, MD, Namrata Shah, MD, Kristin Richardson, MD, George Carrum, MD, Parameswaran Hari, MD MRCP, MS, Mehdi Hamadani, MD, Sai Ravi Pingali, MD, Reem Karmali, MD MS, Timothy S. Fenske, MD

Blood (2015) 126 (23): 3169.

https://doi.org/10.1182/blood.V126.23.3169.3169

Published: 2015

Journal Articles

Age over 55 Years at Diagnosis Increases Risk of Second Malignancies after Auto-Transplantation for Hodgkin's Lymphoma Patients

Sai Ravi Pingali, MD, Rima Saliba, Paolo Anderlini, MD, Chitra M. Hosing, MD, Issa F. Khouri, MD, Amin M. Alousi, MD, Partow Kebriaei, MD, Yago Nieto, MD PhD, Muzaffar H. Qazilbash, MD, Michelle A. Fanale, Elizabeth J. Shpall, MD, Richard E. Champlin, MD, Uday R. Popat, MD

Blood (2015) 126 (23): 3186.

https://doi.org/10.1182/blood.V126.23.3186.3186

Published: 2015

Journal Articles

Leukapheresis Reduces 4-Week Mortality in Leukemia Patient with Hyperleukocytosis-a Retrospective Study from a Tertiary Center

Nan Xinyu, Srivastava Pallavi, Mamta Puppala, MSc, Sai Ravi Pingali, MD, Ibrahim Ibrahim, Lawrence Rice, MD, Alexandria T. Phan, MD, Swaminathan Padmanabhan Iyer, MD

Blood (2015) 126 (23): 3782.

https://doi.org/10.1182/blood.V126.23.3782.3782

Published: 2015

Journal Articles

Staphylococcus Species Leads the Eskape Infections in Various Hematological Malignancies

Purnima Sravanti Teegavarapu, MD, Mamta Puppala, MSc, Sai Ravi Pingali, MD, Asmita Patel, Ibrahim Ibrahim, MD, Akash Mukherjee, MD, Lawrence Rice, MD, Swaminathan Padmanabhan Iyer, MD

Blood (2015) 126 (23): 4623.

https://doi.org/10.1182/blood.V126.23.4623.4623

Published: 2015

Journal Articles

Impact of Routine Surveillance Imaging on Outcomes in Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Undergoing Autologous Hematopoietic Cell Transplantation (auto-HCT)

Narendranath Epperla, MD, Namrata Shah, MD, Kristin Richardson, MD, Jonathan Kapke, DO, George Carrum, MD, Parameswaran Hari, MD MRCP, MS, Mehdi Hamadani, MD, Sai Ravi Pingali, MD, Reem Karmali, MD MS, Timothy S. Fenske, MD

Blood (2015) 126 (23): 4360.

https://doi.org/10.1182/blood.V126.23.4360.4360

Published: 2015

Journal Articles

Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia

Blood (2015) 126 (8): 1033–1040.

https://doi.org/10.1182/blood-2015-04-639831

Published: 2015

Includes: Supplemental data

Journal Articles

Survival after T-Cell Replete Haplo-Identical Related Donor Transplant Using Post-Transplant Cyclophosphamide Compared with Matched Unrelated Donor Transplant for Acute Myeloid Leukemia

Blood (2014) 124 (21): 679.

https://doi.org/10.1182/blood.V124.21.679.679

Published: 2014

Journal Articles

Transplant Outcomes of 9/10 HLA Matched Unrelated Donors (MUD) Treated with Post-Transplant Cyclophosphamide for Prevention of Graft Versus Host Disease

Sai Ravi Pingali, MD, Denai Milton, MS, Uday R. Popat, MD, Chitra M. Hosing, Qaiser Bashir, Amin M. Alousi, MD, Roy Jones, Yago Nieto, Partow Kebriaei, Muzaffar H. Qazilbash, MD, Borje S Andersson, MD PhD, Elizabeth J Shpall, MD, Issa F. Khouri, MD, Richard E. Champlin, Stefan O. Ciurea, MD

Blood (2014) 124 (21): 2486.

https://doi.org/10.1182/blood.V124.21.2486.2486

Published: 2014

Journal Articles

Haploidentical Transplantation For Patients With Advanced Hematologic Malignancies With Melphalan-Based Conditioning – Interim Results From a Phase II Clinical Trial

Sai Ravi Pingali, MD, Milton Denai, M S, Antonio Di Stasi, MD, Partow Kebriaei, MD, Uday R Popat, MD, Amin Alousi, MD, Paolo Anderlini, MD, Simrit Parmar, MD, Chitra M. Hosing, MD, Borje S. Andersson, MD, PhD, Qaiser Bashir, MD, Sairah Ahmed, MD, Betul Oran, MD, Elizabeth J Shpall, MD, Issa Khouri, MD, Marina Konopleva, MD, PhD, Gheath Alatrash, D.O., Ph.D., Richard E Champlin, MD, Stefan O. Ciurea, MD

Blood (2013) 122 (21): 4523.

https://doi.org/10.1182/blood.V122.21.4523.4523

Published: 2013

Journal Articles

Number Of Apheresis Days To Reach Target Stem Cell Dose May Be a Predictor Of Secondary Myelodysplastic Syndrome and Acute Myelogenous Leukemia

Sai Ravi Pingali, MD, Rima M Saliba, PhD, Veronica R. Smith, APN, Farzaneh Maadani, Kehinde U.A. Adekola, MBBS, Uday R Popat, MD, Muzaffar H. Qazilbash, MD, Qaiser Bashir, MD, Issa Khouri, MD, Partow Kebriaei, MD, Stefan O. Ciurea, MD, Paolo Anderlini, MD, Nina Shah, MD, Yago Nieto, MD, PhD, Richard E Champlin, MD, Chitra M. Hosing, MD

Blood (2013) 122 (21): 4515.

https://doi.org/10.1182/blood.V122.21.4515.4515

Published: 2013

Journal Articles

Characteristics Of Multiple Myeloma Patients With 6-Year Or Longer Progression-Free Survival After a Single Autologous Transplant

Kehinde U.A. Adekola, MD, Qaiser Bashir, MD, Nina Shah, MD, Sai Ravi Pingali, MD, Simrit Parmar, MD, Uday R Popat, MD, Chitra M. Hosing, MD, Richard E Champlin, MD, Muzaffar H. Qazilbash, MD

Blood (2013) 122 (21): 3366.

https://doi.org/10.1182/blood.V122.21.3366.3366

Published: 2013

NARROW

Primary Vitreoretinal Lymphoma with or without Intracranial Involvement: A Single Center Experience

RARγ activation sensitizes human myeloma cells to carfilzomib treatment through the OAS-RNase L innate immune pathway

MIF as a biomarker and therapeutic target for overcoming resistance to proteasome inhibitors in human myeloma

An Integer Weighted Genomic Mutation Scoring (IWGMS) Using the Trusight Myeloid Sequencing Panel (Illumina) Shows Higher Mortality in Patients with Intermediate Risk Acute Myeloid Leukemia- a Retrospective Study

Impact of Routine Surveillance Imaging on Outcomes in Patients with Classical Hodgkin Lymphoma (cHL) Undergoing Autologous Hematopoietic Cell Transplantation (auto-HCT)

Age over 55 Years at Diagnosis Increases Risk of Second Malignancies after Auto-Transplantation for Hodgkin's Lymphoma Patients

Leukapheresis Reduces 4-Week Mortality in Leukemia Patient with Hyperleukocytosis-a Retrospective Study from a Tertiary Center

Staphylococcus Species Leads the Eskape Infections in Various Hematological Malignancies

Impact of Routine Surveillance Imaging on Outcomes in Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Undergoing Autologous Hematopoietic Cell Transplantation (auto-HCT)

Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia

Survival after T-Cell Replete Haplo-Identical Related Donor Transplant Using Post-Transplant Cyclophosphamide Compared with Matched Unrelated Donor Transplant for Acute Myeloid Leukemia

Transplant Outcomes of 9/10 HLA Matched Unrelated Donors (MUD) Treated with Post-Transplant Cyclophosphamide for Prevention of Graft Versus Host Disease

Haploidentical Transplantation For Patients With Advanced Hematologic Malignancies With Melphalan-Based Conditioning – Interim Results From a Phase II Clinical Trial

Number Of Apheresis Days To Reach Target Stem Cell Dose May Be a Predictor Of Secondary Myelodysplastic Syndrome and Acute Myelogenous Leukemia

Characteristics Of Multiple Myeloma Patients With 6-Year Or Longer Progression-Free Survival After a Single Autologous Transplant

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only